Mawi DNA Technologies Announces New Distribution Partnership…READ MORE
It is with great delight and excitement that we announce that Dr. Mark Bouzyk has joined Mawi DNA Technologies’s board as a scientific advisor! Dr. Bouzyk has a distinguished career in genomics with a long list of impressive accomplishments and contributions. We are honored and humbled to add him…READ MORE
Mawi DNA Awarded Leading Innovators of Biosample Collection Technology 2022
The Global Health & Pharma (GH&P) Magazine awarded Mawi DNA Technologies with the 2022 Leading Innovators of Biosample Collection Technology Award. Mawi DNA is honored to be recognized for this achievement and continues to develop innovative technologies for universal sample collection. “I strongly believe that science is…READ MORE
Announcing Mawi DNA’s Joint venture with our local partner BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market.
Announcing Mawi DNA's joint venture with BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market. This will be accomplished via the unique and innovative biosampling technology set forth by Mawi DNA. BIOTESSIA's strategy and vision are centered around ensuring health needs…READ MORE
Achieve faster, more accurate COVID-19 results with the NextSWAB
Testing for infectious disease SARS-CoV-2 using the NextSWAB 100% medical-grade plastic molded swab – outperforms flocked swabs in many applications Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces its launch of a new product in response to…READ MORE
Mawi DNA Technologies Awarded Two ISO Certifications
Hayward, CA - February 9, 2022 – Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management Systems certifications. Mawi developed and commercialized the iSWAB technology, an innovative…READ MORE
Mawi maintains robust stock of COVID testing supplies with USA-Based, uninterrupted supply chain.
Mawi’s iSWAB technology is available in various quantities to support large and small COVID testing sites with no supply chain delays. We are proud to say that over the course of this pandemic we have never experienced supply chain issues. We have full control over…READ MORE
iSWAB Microbiome collection media approved for home collection of COVID-19 samples; Mawi maintains robust stock of testing supplies
The University of California, San Diego (UCSD) EXCITE lab has been extensively using Mawi’s iSWAB-Microbiome technology for campus and community surveillance. Mawi DNA Technologies is honored to announce the FDA has granted Emergency Use Authorization (EUA) for UCSD Excite Lab’s COVID test, submitted with iSWAB-Microbiome…READ MORE
Mawi and CosmosID Collaborate to Enable More Precise Microbiome Analysis
HAYWARD, CA – January 13, 2020 - Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces a collaboration with CosmosID to help advance understanding of microbiome complexity in different biological samples and environments. “Our fellow microbiome researchers have…READ MORE
iSWAB-Cells Now Available!
Mawi DNA Technologies is pleased to announce the release of the new iSWAB-Cells Collection System and Cell Stabilization Buffer! Link to the Press Release: https://www.businesswire.com/news/home/20180924005306/en/Mawi-DNA-Technologies-Launches-iSWAB-Cell-Stabilization Product Page: iSWAB-Cells Collection System and… read more →READ MORE
iSWAB Patent granted for the EU!
The European Patent Office (EPO) issued a Decision to Grant Mawi DNA Technologies their patent for the EU with regards to iSWAB-Sample collection technology. The patent issued on August 29, 2018. For more information visit this link: https://patents.google.com/patent/EP2958498B1/enREAD MORE